Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2766-42-9

Post Buying Request

2766-42-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2766-42-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2766-42-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,6 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2766-42:
(6*2)+(5*7)+(4*6)+(3*6)+(2*4)+(1*2)=99
99 % 10 = 9
So 2766-42-9 is a valid CAS Registry Number.

2766-42-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-(1-hydrazinyl-3-hydroxy-1-oxopropan-2-yl)carbamate

1.2 Other means of identification

Product number -
Other names Boc-Ser-N2H3

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2766-42-9 SDS

2766-42-9Relevant articles and documents

A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.

Goldberg, Joel A.,Kumar, Vijay,Spencer, Elizabeth J.,Hoyer, Denton,Marshall, Steven H.,Hujer, Andrea M.,Hujer, Kristine M.,Bethel, Christopher R.,Papp-Wallace, Krisztina M.,Perez, Federico,Jacobs, Michael R.,van Duin, David,Kreiswirth, Barry N.,van den Akker, Focco,Plummer, Mark S.,Bonomo, Robert A.

, (2021)

Serious infections caused by multidrug-resistant (MDR) organisms (Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii) present a critical need for innovative drug development. Herein, we describe the preclinical evaluation of YU253911,

SIDEROPHORE CONJUGATED PYRAZOLIDINONES, AND ANALOGUES THEREOF

-

Page/Page column 21, (2020/02/14)

In one aspect, the invention provides compounds and methods that are useful for treating bacterial infections.

Synthesis method of benserazide hydrochloride

-

Paragraph 0126; 0127; 0130; 0131, (2019/12/11)

The invention relates to a synthesis method of benserazide hydrochloride. According to the synthesis method, serine methyl ester hydrochloride is taken as the primary raw material, at first, amino protection reactions are carried out; and then amine-ester exchange reactions, condensation reactions, reduction reactions, and de-protection reactions are performed to obtain high purity benserazide hydrochloride. The synthesis method has the advantages that the raw materials are cheap and easily available, the operation is convenient, the product purity and yield of each step are high, and thus thesynthesis method is suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2766-42-9